Guangdong Taienkang Pharmaceutical Co. Ltd Cash Flow-to-Debt Ratio
Guangdong Taienkang Pharmaceutical Co. Ltd cash flow-to-debt ratio. Guangdong Taienkang Pharmaceutical Co. Ltd (301263) has a Cash Flow-to-Debt Ratio of -0.02x as of December 2025, meaning its operating cash flow of CN¥-12.88 Million could theoretically repay 0% of its total liabilities (CN¥676.07 Million) in one year. Check 301263 total capital reinvestment ratio to assess the company's total reinvestment commitment from operating cash flow.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Cash Flow-to-Debt Ratio of Guangdong Taienkang Pharmaceutical Co. Ltd (2019–2025)
Cash flow-to-debt ratio of Guangdong Taienkang Pharmaceutical Co. Ltd from 2019 to 2025. Historical debt coverage capacity for Guangdong Taienkang Pharmaceutical Co. Ltd across 7 annual periods. Check 301263 cash flow quality index to evaluate the quality of earnings relative to operating cash generation.
Guangdong Taienkang Pharmaceutical Co. Ltd Cash Flow-to-Debt Ratio by Year (2019–2025)
Guangdong Taienkang Pharmaceutical Co. Ltd cash flow-to-debt ratio by year from 2019 to 2025. Year-by-year debt coverage analysis for Guangdong Taienkang Pharmaceutical Co. Ltd. For the full cash flow conversion analysis, see 301263 cash generation efficiency.
| Year | CF-to-Debt Ratio | Operating CF (CNY) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | -0.02x | CN¥-12.88 Million | CN¥676.07 Million | ▼ -110.5% |
| 2024 | 0.18x | CN¥89.33 Million | CN¥494.67 Million | ▼ -22.8% |
| 2023 | 0.23x | CN¥93.53 Million | CN¥399.72 Million | ▼ -70.8% |
| 2022 | 0.80x | CN¥148.81 Million | CN¥185.63 Million | ▲ +54.8% |
| 2021 | 0.52x | CN¥120.02 Million | CN¥231.71 Million | ▲ +1.1% |
| 2020 | 0.51x | CN¥125.53 Million | CN¥245.12 Million | ▲ +23.0% |
| 2019 | 0.42x | CN¥75.44 Million | CN¥181.16 Million | — |